The gut microbiota in high-altitude medicine: intersection of hypoxic adaptation and disease management
Frontiers in Microbiology · 05.11.2025 · 16
DOI: 10.3389/fmicb.2025.1705487 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 05.11.2025. Verfasst von Qian Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
High-altitude exposure impacts hundreds of millions globally, posing a unique health challenge due to extreme stressors including hypobaric hypoxia and intense ultraviolet radiation. The gut microbiota, a microbial community residing in the intestinal tract, plays a pivotal role in maintaining host health through homeostasis. Emerging evidence highlights the gut microbiome's dual roles in facilitating host adaptation to high-altitude environments and in mediating maladaptive responses. This review explores the potential changes and mechanisms of the gut microbiota and its metabolites in mediating host adaptation and pathogenesis related to high-altitude exposure, alongside summarizing effective strategies for targeted microbiota modulation to prevent and treat altitude-related disorders. Furthermore, we discuss the influence of microbiota on drug metabolism in high-altitude populations and its potential role as diagnostic and prognostic biomarkers. Although current research remains exploratory, the gut microbiome has garnered significant interest in high-altitude medicine. With advancing investigations, microbiota-targeted interventions may emerge as critical breakthroughs for altitude disease management, paving the way for improved human adaptation to extreme environments and precision health strategies for plateau populations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Friedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland.
- Department of Pediatrics, Harvard Medical School, Boston Children's Hospital, Boston, MA, United States.
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Zitieren
APA
Chen, Q., Huang, D., Liu, J., Jia, N., Shen, Z., Pei, C., Chen, C., Liu, Y., Wang, Y., Shi, S., Yi, R., He, Y., Wang, F., & Wang, Z. (2025). The gut microbiota in high-altitude medicine: intersection of hypoxic adaptation and disease management. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1705487
Vancouver
Chen Q, Huang D, Liu J, Jia N, Shen Z, Pei C, et al. The gut microbiota in high-altitude medicine: intersection of hypoxic adaptation and disease management. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1705487
BibTeX
@article{Chen2025,
author = {Chen, Qian and Huang, Demei and Liu, Junling and Jia, Nan and Shen, Zherui and Pei, Caixia and Chen, Chen and Liu, Yuhan and Wang, Yilan and Shi, Shihua and Yi, Renxing and He, Yacong and Wang, Fei and Wang, Zhenxing},
title = {The gut microbiota in high-altitude medicine: intersection of hypoxic adaptation and disease management},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1705487}
}
EUVIMED